Papaverine Hydrochloride Injection, Solution
NDC Package 54288-142-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Papaverine Hydrochloride injection is papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states, and visceral spasm, as in ureteral, biliary, or gastrointestinal colic. This formulation utilizes a injection, solution delivery system. Marketed by Bpi Labs Llc, this product is identified by NDC 54288-142.

Identification & Billing

NDC Package Code
54288-142-10
Package Description
10 VIAL in 1 CARTON / 2 mL in 1 VIAL (54288-142-01)
Product Code
54288-142
11-Digit Billing Format
54288014210
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Papaverine Hydrochloride
Non-Proprietary Name
Papaverine Hydrochloride
Substance Name
Papaverine Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Parenteral - Administration by injection, infusion, or implantation.
Active Ingredient(s)
PAPAVERINE HYDROCHLORIDE 30 mg/mL
Usage Information
Papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states, and visceral spasm, as in ureteral, biliary, or gastrointestinal colic.

Regulatory & Marketing

Labeler Name
Bpi Labs Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
07-10-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J2440
Source: PDAC
INJECTION, PAPAVERINE HCL, UP TO 60 MG
HCPCS Dosage 60 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (54288-142). Click a package code to view its specific billing and regulatory data.

54288-142-25
25 VIAL in 1 CARTON / 2 mL in 1 VIAL (54288-142-01)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54288-142-10 identifies a specific commercial package of 10 vial in 1 carton / 2 ml in 1 vial (54288-142-01) of Papaverine Hydrochloride, a human prescription drug labeled by Bpi Labs Llc. This injection, solution is formulated for intramuscular; intravenous; parenteral use and contains papaverine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bpi Labs Llc on July 10, 2021. The current certification is valid through December 31, 2026.

How is this Bpi Labs Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54288014210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54288-142-10
11-Digit CMS (5-4-2)
54288-0142-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.